Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BLU-701 |
| Trade Name | |
| Synonyms | BLU701|BLU 701 |
| Drug Descriptions |
BLU-701 is a reversible EGFR inhibitor that blocks the activity of mutant forms of EGFR, including C797S, while sparing wild-type EGFR, which results in reduced downstream signaling and potentially leads to decreased tumor growth (Cancer Res 2021;81(13_Suppl):Abstract nr 1262). |
| DrugClasses | EGFR Inhibitor 4th gen 19 |
| CAS Registry Number | NA |
| NCIT ID | C185863 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BLU-701 | BLU-701 | 0 | 1 |
| BLU-701 + Carboplatin + Pemetrexed Disodium | BLU-701 Carboplatin Pemetrexed Disodium | 0 | 1 |
| BLU-701 + Osimertinib | BLU-701 Osimertinib | 0 | 1 |